Foundayo
Orforglipron, sold under the brand name Foundayo, is a medication used for weight management. It is an oral, non-peptide, small-molecule GLP-1 receptor agonist developed as a weight loss drug by Eli Lilly and Company. , then was licensed to Lilly in 2018. Wikipedia, CC BY-SA 4.0
- Stories this week
- 1
- Today
- 0
Coverage this week
Separate stories naming Foundayo, by day.
| Day | Stories |
|---|---|
| Thu | 0 |
| Fri | 0 |
| Sat | 0 |
| Sun | 0 |
| Mon | 0 |
| Tue | 1 |
| Today | 0 |